Addus HomeCare price target raised to $96 from $92 at Barclays
Barclays analyst Andrew Mok raised the firm's price target on Addus HomeCare to $96 from $92 and keeps an Underweight rating on the shares. The firm adjusted targets among its U.S. healthcare facilities and managed care coverage ahead of Q2 earnings from the group.
Barclays analyst Andrew Mok raised the firm's price target on Addus HomeCare to $96 from $92 and keeps an Underweight rating on the shares.
The firm adjusted targets among its U.S. healthcare facilities and managed care coverage ahead of Q2 earnings from the group.